Efficacy and safety of generic imatinib mesylate capsules produced in China for newly diagnosed chronic myeloid leukemia in chronic phase patients.
- Author:
Juan CHEN
1
;
Li ZHOU
1
;
Shenghong DU
1
;
Hongying LU
1
;
Shujun SUN
1
;
Junmin LI
1
;
Weili ZHAO
1
;
Zhixiang SHEN
1
Author Information
- Publication Type:Journal Article
- MeSH: Capsules; China; Drugs, Generic; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase
- From: Chinese Journal of Hematology 2015;36(3):235-237
- CountryChina
- Language:Chinese
